Impact of C1q fixing donor‐specific antibodies on renal transplant outcome
暂无分享,去创建一个
[1] E. Lerut,et al. Specificity, strength, and evolution of pretransplant donor‐specific HLA antibodies determine outcome after kidney transplantation , 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[2] P. Aljama,et al. Impact of Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibody C1q-Binding Ability on Kidney Allograft Outcome , 2017, Front. Immunol..
[3] Song Zhang,et al. Complement (C1q) Binding De Novo Donor-Specific Antibodies and Cardiac-Allograft Vasculopathy in Pediatric Heart Transplant Recipients , 2017, Transplantation.
[4] X. Jouven,et al. Value of Donor-Specific Anti-HLA Antibody Monitoring and Characterization for Risk Stratification of Kidney Allograft Loss. , 2017, Journal of the American Society of Nephrology : JASN.
[5] N. Mehra,et al. Clinical and immunological relevance of antibodies in solid organ transplantation , 2016, International journal of immunogenetics.
[6] T. Fehr,et al. Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing , 2015, Transplantation.
[7] S. Rattanasiri,et al. Significance of C1q-fixing donor-specific antibodies after kidney transplantation. , 2014, Transplantation proceedings.
[8] L. Chatenoud,et al. Outcome of Kidney Transplantations Performed With Preformed Donor‐Specific Antibodies of Unknown Etiology , 2014, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[9] J. Pascual,et al. Clinical relevance of pretransplant anti-HLA donor-specific antibodies: does C1q-fixation matter? , 2013, Transplant immunology.
[10] X. Jouven,et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. , 2013, The New England journal of medicine.
[11] Wuding Zhou,et al. The role of complement in the early immune response to transplantation , 2012, Nature Reviews Immunology.
[12] P. Nickerson,et al. Evolution and Clinical Pathologic Correlations of De Novo Donor‐Specific HLA Antibody Post Kidney Transplant , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[13] S. Sutherland,et al. Complement‐fixing donor‐specific antibodies identified by a novel C1q assay are associated with allograft loss , 2012, Pediatric transplantation.
[14] D. Tyan,et al. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. , 2011, Human immunology.
[15] G. Berry,et al. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[16] P. Terasaki,et al. Significance of the positive crossmatch test in kidney transplantation. , 1969, The New England journal of medicine.
[17] S. Webber,et al. Human leukocyte antigen epitope analysis to assess complement- and non-complement-binding donor-specific antibody repertoire in a pediatric heart transplant recipient. , 2012, Human immunology.